The Center for Medicare and Medicaid Service’s decision to automatically provide Medicare add-on payments for existing and future hospital drugs to treat COVID-19 demonstrates the agency’s recognition that supplemental reimbursement is crucial for ensuring access to new treatments.
The policy is announced in an interim final rule released on 28 October that also addresses Medicare reimbursement for...







